Literature DB >> 3349231

A comparison between atria from control and streptozotocin-diabetic rats: the effects of dietary myoinositol.

A Kofo-Abayomi1, P D Lucas.   

Abstract

1. Atria, isolated from control rats, six-week streptozotocin-diabetic rats and from similarly diabetic rats treated with myo-inositol (MI) were compared. The MI treatment was shown to reverse the depressed sciatic nerve MI which was observed in the untreated diabetic group. 2. Spontaneously beating atria from the untreated diabetic animals beat more slowly, and with greater force than tissues from the control group. When electrically driven at 4 Hz they were found to be less sensitive to the negative inotropic effect of acetylcholine. No differences between the two groups were observed in responses to isoprenaline. 3. Intramural nerve stimulation in the presence of 10(-6)M propranolol (vagal stimulation) had a greater negative inotropic effect in the untreated diabetic rat atria than in the controls. Positive inotropic responses to nerve stimulation in the presence of 10(-6) M atropine (sympathetic stimulation) were not significantly different between the two groups. 4. Atria from the MI-treated diabetic animals were found to have a lower spontaneous contractile force and greater sensitivity to acetylcholine than tissues from the untreated diabetic animals. The values obtained in both cases were similar to those from the controls. No significant effect of MI treatment on spontaneous contractile rate or on responses to nerve stimulation was demonstrated. 5. Atrial (mainly myocardial) MI was measured in additional control, six-week diabetic and six-week MI-treated diabetic animals. A significantly higher concentration was observed in the MI supplemented group compared to the untreated diabetic group. The mean MI content in the latter group was lower than that obtained from control tissues but not significantly so. 6. The results implicate MI depletion either in the neurones or in the myocardium in at least some of the changes observed. Possible mechanisms involved are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3349231      PMCID: PMC1853771          DOI: 10.1111/j.1476-5381.1988.tb11399.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Comparison between spontaneously beating atria from control and streptozocin-diabetic rats.

Authors:  J M Foy; P D Lucas
Journal:  J Pharm Pharmacol       Date:  1978-09       Impact factor: 3.765

2.  Agonist and guanine nucleotide modulation of muscarinic cholinergic receptors in cultured heart cells.

Authors:  J B Galper; T W Smith
Journal:  J Biol Chem       Date:  1980-10-25       Impact factor: 5.157

3.  Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.

Authors:  D A Greene; A M Mackway
Journal:  Diabetes       Date:  1986-10       Impact factor: 9.461

4.  Cardiac denervation in diabetes.

Authors:  T Wheeler; P J Watkins
Journal:  Br Med J       Date:  1973-12-08

5.  Vagal control of heart period in alloxan diabetic rats.

Authors:  S L Stuesse; D W Wallick; S Mace
Journal:  Life Sci       Date:  1982-07-26       Impact factor: 5.037

Review 6.  Diabetic autonomic neuropathy.

Authors:  B F Clarke; D J Ewing; I W Campbell
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

7.  Sarcolemmal Na+-K+-ATPase activity in diabetic rat heart.

Authors:  G N Pierce; N S Dhalla
Journal:  Am J Physiol       Date:  1983-09

8.  Na-K activated ATPase and the release of acetylcholine and noradrenaline.

Authors:  E S Vizi; T Tŏrŏk; A Seregi; P Serfŏzŏ; V Adam-Vizi
Journal:  J Physiol (Paris)       Date:  1982

9.  Effect of alloxan- and streptozotocin-induced diabetes on isolated rat heart responsiveness to carbachol.

Authors:  R V Vadlamudi; J H McNeill
Journal:  J Pharmacol Exp Ther       Date:  1983-05       Impact factor: 4.030

10.  Effect of experimental diabetes, food deprivation and genetic obesity on the sensitivity of pithed rats to autonomic agents.

Authors:  J M Foy; P D Lucas
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

View more
  7 in total

1.  Tissue noradrenaline and the polyol pathway in experimentally diabetic rats.

Authors:  P D Lucas; A Qirbi
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

2.  Effect of 5-hydroxytryptamine on [3H]-acetylcholine release from guinea-pig striatal slices.

Authors:  C Bianchi; A Siniscalchi; L Beani
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

3.  Effects of carbenoxolone on heart rhythm, contractility and intracellular calcium in streptozotocin-induced diabetic rat.

Authors:  F C Howarth; M A Qureshi
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

4.  Diabetes increases mortality after myocardial infarction by oxidizing CaMKII.

Authors:  Min Luo; Xiaoqun Guan; Elizabeth D Luczak; Di Lang; William Kutschke; Zhan Gao; Jinying Yang; Patric Glynn; Samuel Sossalla; Paari D Swaminathan; Robert M Weiss; Baoli Yang; Adam G Rokita; Lars S Maier; Igor R Efimov; Thomas J Hund; Mark E Anderson
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

5.  Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.

Authors:  P C Moser; M D Tricklebank; D N Middlemiss; A K Mir; M F Hibert; J R Fozard
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

6.  Altered expression of gap junction connexin proteins may partly underlie heart rhythm disturbances in the streptozotocin-induced diabetic rat heart.

Authors:  F C Howarth; N Nowotny; E Zilahi; M A El Haj; M Lei
Journal:  Mol Cell Biochem       Date:  2007-07-14       Impact factor: 3.396

7.  Effects of streptozotocin-induced diabetes on action potentials in the sinoatrial node compared with other regions of the rat heart.

Authors:  F C Howarth; R Al-Sharhan; A Al-Hammadi; M A Qureshi
Journal:  Mol Cell Biochem       Date:  2006-11-25       Impact factor: 3.842

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.